According to a market report by Lucintel, the future of the global steam inhaler device market looks promising with opportunities in the hospital and clinic markets. The global steam inhaler device market is expected to reach an estimated $3.6 billion by 2030 from $2.4 billion in 2024, at a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of respiratory diseases, growing adoption of a single inhaler triple therapy for COPD treatment, and rising demand for home-based healthcare.
A more than 150-page report to understand trends, opportunity and forecast in steam inhaler device market to 2030 by product type (warm steam inhalers, cool mist inhalers, and nebulizing steam inhalers), application (cold and congestions, asthma, chronic obstructive pulmonary disease, and others), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the product type category, warm steam inhaler will remain the largest segment over the forecast period due to its cost-effective and environmentally friendly in nature.
Within the end use category, hospital will remain the larger segment.
Download sample by clicking on steam inhaler device market
In terms of regions, North America will remain the largest region over the forecast period due to growing awareness towards respiratory disorders, robust healthcare infrastructure, and presence of major players in the region.
Vicks, MyPurMist, Gurin, Uniclife, HealthSmart, Veridian Healthcare, Vanker, Leica Biosystems, Guardian Technologies, Kaz are the major suppliers in the steam inhaler device market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Electroencephalogram Disposable Medical Electrodes Market
Network Analytic Market
Citrate Ester-Based Plasticizer Market
Algae Product Market
Skin Cancer Diagnostics & Therapeutics Market